Out Of Stock
|Manufacturer||Natco Pharma, India|
Erlonat 100 mg is a prescription treatment for patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGFR mutations. It is effective in treating patients with locally advanced or metastatic NSCLC who have previously received chemotherapy. Erlonat, in combination with gemcitabine, is used to treat patients with locally advanced, or metastatic cancer. The medicines contain the active substance Erlotinib, which treats cancer by preventing the activity of a protein called epidermal growth factor receptor (EGFR), a protein involved in the growth and spread of cancer cells.
The recommended daily dose for patients with pancreatic cancer is 100 mg at least one hour before or two after consuming food. The medicine is taken in combination with gemcitabine. Be sure to follow all the directions given by your physician when it comes to using Erlonat 100 mg. To know about the recommended dose for lung cancer, consult your physician. Always take this anti-cancer drug under the supervision of a physician. The duration of the treatment varies according to your need as well as response to the treatment. One should take medicine in the dose and duration as advised by your physician.
Your physician may advise for regular monitoring of liver function while you are taking Erlonat. Avoid smoking while talking Erlotinib as it makes the medicine ineffective and requires dose adjustment. Females who are undergoing this cancer treatment should use effective contraception method. It is important to avoid pregnancy during the anti-cancer treatment and for a month after completing the course of medicine. This medicine may make you more sensitive to sunlight, so it is advisable always to apply sunscreen and wear protective clothing whenever you step out in the sun. Diarrhoea may occur as the side effects of this anticancer medicine, so it is essential to drink plenty of fluids to reduce the adverse effect. You must inform your physician if it does not resolve or you notice blood in the stools. In case you develop ulceration in the mouth, vision changes, or trouble breathing, then you should inform your physician.
The most common side effects in maintenance treatment are rashes, like events and diarrhoea. Other common side effects experienced by NSCLC are rash cough, nausea, vomiting, infection, dyspnea, and fatigue. The common adverse effects of pancreatic cancer are diarrhoea, oedema, constipation, myalgia, stomatitis, bone pain, dyspnea, weight decrease, abdominal pain, anorexia, and rash. If you get any of these adverse effects, talk to your physician.